New Antidiabetes Pharmaceutical PF
New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729 Function of Ertugliflozin Temozol;
Basic Info.
Model NO. | HRK-PF-04971729 |
Assay | 90% Min |
Grade Standard | Feed Grade, Food Grade, Medicine Grade |
Certificate | GMP ISO USP Bp |
Sample | Ertugliflozin Avaliable |
Storage | Cool Dry Place |
Shelf Life | 2 Years Proper Storage |
Type of Product | Auxiliaries and Other Medicinal Chemicals |
Application | PF-04971729 Raw Materials |
CAS | 1210344-57-2 |
Mf | C22h25clo7 |
Active Ingredient | PF-04971729 |
MW | 436.129 |
Appearance | White or White Crystalline Powder |
Test | HPLC |
Product Name | PF-04971729 Powder |
Transport Package | 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr |
Specification | 99% min PF-04971729 |
Trademark | Henrikang |
Origin | Shaanxi China |
Production Capacity | 500000kg/Year |
Product Description
New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729Product Name | New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729 |
CAS | 1210344-57-2 |
Appearance | White or white crystalline powder |
Molecular formula | C22H25ClO7 |
Molecular Weight | 436.129 |
Assay | 98% |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
What is Ertugliflozin? Ertugliflozin is an antidiabetic drug. Ertugliflozin is used to improve glycemic control in people with type 2 diabetes,Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizer and Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It has been clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed in China. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozin drug research. |
Function of Ertugliflozin
Temozolomide is used in the treatment of adults with refractory pleomorphic glioblastoma and anaplasticastrocytoma of chemotherapy drugs.Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizerand Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It hasbeen clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed inChina. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozindrug research.Company InformationOur CertificateOur ServiceOur ResearchPackaging & Logistics
Package:
1kg per Foil Bag, 10 Bags per carton. 25 kg per Drum. Or Customized Package.2. Shipping Advise:
1. By Express------Suitable for under 50kg, Fast:3-4 days. High cost; Door to door service. Easy to pick up the goods.2. By Air ------Suitable for more than 50 kg, Fast:4-5 days, High cost, airport to airport. professional broker needed.3. By sea------Suitable for more than 500kg. Slow: 15-45 days, Low cost. Port to Port, professional broker needed.why choose us ?New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729Ertugliflozin;PF-04971729;Ertugliflozin Powder
You may also like
Send inquiry
Send now